Natural killer cells in patients with Guillain-Barre syndrome

Journal of the Neurological Sciences

Volumn 157, Issue 2, 1998, Pages 175-178

  Yoshii, Fumihito ^a,b   Shinohara, Yukito ^a  

^a TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Emergency and Critical Care Medicine   (Japan)

Author keywords

Guillain Barre syndrome; Lymphocyte subsets; Natural killer cell activity; Natural killer cells; Plasmapheresis

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; GUILLAIN BARRE SYNDROME; HUMAN; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL; PLASMAPHERESIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; KILLER CELLS, NATURAL; LEUKOCYTE COUNT; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; POLYRADICULONEUROPATHY;

EID: 0032493069     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00065-3     Document Type: Article

References (16)

1. Alberighi ODC, Orazio EN, Bonara Pet al. NK cells in patients with peripheral neuropathy and IgM monoclonal protein reacting with the myelin-associated glycoprotein (MAG). J Neuroimmunol. 18:1988;207-216.
2. Becker JC, Kolanus W, Lonnemann C, Schmidt RE Human natural killer clones enhance in vitro antibody production by tumor necrosis factor alpha and gamma interferon. Scand J Immunol. 32:1990;153-162.
3. Dahle C, Vrethem M, Ernerudh J T lymphocyte subset abnormalities in peripheral blood from patients with the Guillain-Barré syndrome. J Neuroimmunol. 53:1994;219-225.
4. Kastrukoff LF, Morgan NG, Aziz TM, Zecchini D, Berkowitz J, Paty DW Natural killer (NK) cells in chronic progressive multiple sclerosis patients treated with lymphoblastoid interferon. J Neuroimmunol. 20:1988;15-23.
5. Kuwano K, Arai S, Munataka T, Tomita Y, Yoshitake Y, Kumagai K Suppressive effect of human natural killer cells on Epstein-Barr virus-induced immunoglobulin synthesis. J Immunol. 137:1986;1462-1467.
6. Michael A, Hackett JJ, Bennett M, Kumar V, Yuan D Regulation of B lymphocytes by natural killer cells. Role of IFN-γ J Immunol. 142:1989;1095-1101.
7. Murray N, Steck AJ Indication of a possible role in a demyelinating neuropathy for an antigen shared between myelin and NK cells. Lancet. 2:1984;711-712.
8. Neighbour PA, Grayzel AI, Miller AE Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis. Clin Exp Immunol. 49:1982;11-21.
9. Pedersen BK, Tvede N, Hansen FRet al. Modulation of natural killer cell activity in peripheral blood by physical exercise. Scand J Immunol. 27:1988;673-678.
10. Schuller-Petrovic S, Gebhart W, Lassmann H, Rumpold H, Kraft D A shared antigenic determinant between natural killer cells and nervous tissue. Nature. 306:1983;179-181.
11. Shah PD, Gilbertson SM, Rowley DA Dendritic cells that have interacted with antigen are targets for natural killer cells. J Exp Med. 162:1985;625-636.
12. Sriram S, Lanier L NK cell function in a patient with IgM monoclonal antibody against myelin-associated glycoprotein. Neurology. 36:1986;566-568.
13. Tanaka M, Nishizawa T, Inuzuka H, Baba S, Sato S, Miyatake T Human natural killer cell activity is reduced by treatment of anti-myelin-associated glycoprotein (MAG) monoclonal mouse IgM antibody and complement. J Neuroimmunol. 10:1985;115-127.
14. van der Meché FGA, van Doorn PA Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy: immune mechanisms and update on current therapies. Ann Neurol. 37(S1):1995;S14-S31.
15. Vrethem M, Dahle C, Ekerfeldt C, Nilsson J, Ekstedt B, Ernerudh J Abnormalities in T-lymphocyte populations in blood from patients with demyelinating polyneuropathy associated with monoclonal gammopathy. J Neurol Sci. 122:1994;171-178.
16. Winer JB, Hughes RAC, Osmond C A prospective study of acute idiopathic neuropathy. I. Clinical features and their prognostic value. J Neurol Neurosurg Psychiatry. 51:1988;605-612.